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Abstract 
DOES TRANSDERMAL NICOTINE-INDUCED WITHDRAWAL SUPPRESSION 
DEPEND ON SMOKERS' GENDER? 
By Sarah E. Evans 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2005 
Major Director: Dr. Thomas Eissenberg, Associate Professor, Department of Psychology 
and Institute for Drug and Alcohol Studies 
Nicotine replacement therapy (NRT) is a pharmacotherapy used commonly to 
help tobacco smokers quit smoking. All forms of NRT are demonstrably efficacious for 
this indication, and several forms, including transdermal nicotine (TN) are available over- 
the-counter in the United States. NRT is less efficacious in women than in men, although 
the specific reasons for this gender difference are unknown. ' JRT generally, and TN 
specifically, is thought to work, at least in part, by suppressing withdrawal symptoms in 
abstinent smokers. While TN-induced withdrawal suppression has been demonstrated, 
the degree to which this withdrawal suppression is influenced by smokers' gender is 
uncertain. The purpose of this acute laboratory study is to determine if TN-induced 
withdrawal suppression is influenced by smokers' gender. 
One hundred twenty eight overnight-abstinent smokers completed four, double- 
blind, randomized, 6.5-hour laboratory sessions in which further cigarette abstinence was 
required. Sessions differed by TN dose (0, 7,2 1, or 42 mg). All sessions were double- 
blind and randomly ordered. Each session included regular assessment of subjective 
symptoms of nicotine/tobacco withdrawal, subjective effects of transdermal nicotine 
dose, psychomotor performance, heart rate and plasma nicotine level. Results from this 
laboratory study revealed clear nicotine dose-related effects for plasma nicotine and heart 
rate, symptoms of nicotine intoxication (e.g. Nausea, Lightheaded) and suppression of 
Urges to smoke and Craving. Many DSM IV nicotine/tobacco withdrawal symptoms did 
not show dose-related suppression (e.g. Irritability/frustration/anger, Anxious, Difficulty 
concentrating). Importantly, results from this study indicated that there were very few 
differences between men and women in nicotine-induced suppression of the 
nicotine/tobacco withdrawal syndrome. Future research addressing this important issue 
may benefit from focusing on a potential interaction between gender and other effects of 
TN (i.e., blunting the effects of a concurrently administered cigarette) and/or on other 
triggers for relapse (i.e., smoking-related stimuli). 





























































































































































































